---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-017313"
form_type: "8-K"
ticker: null
cik: "0001069308"
company_name: "Acer Therapeutics Inc."
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T19:45:05.442116+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Acer Therapeutics receives Nasdaq delisting notice for MVLS below $35M; 180-day compliance period

## Summary
- Nasdaq notified Acer on May 3, 2023 that MVLS was below $35M for 30 consecutive business days, violating rule 5550(b)(2).
- Company has until October 30, 2023 to regain compliance by achieving MVLS ≥ $35M for 10 consecutive trading days.
- Alternatively, Acer can regain compliance by maintaining minimum stockholders' equity of $2.5 million.
- If compliance not regained, Nasdaq may delist shares; company can appeal to a Hearings Panel.

## SEC filing metadata
- accession: 0000950170-23-017313
- form_type: 8-K
- cik: 0001069308
- company_name: Acer Therapeutics Inc.
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069308/000095017023017313/0000950170-23-017313-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069308/000095017023017313/acer-20230503.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-017313
- JSON: https://secwatch.observer/filing/0000950170-23-017313.json
- Plain text: https://secwatch.observer/filing/0000950170-23-017313.txt

## Key facts
- Listing & Compliance Notices
  Acer Therapeutics Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 5550(b)(2)
  source text: May 3, 2023, Acer Therapeutics Inc. (the “Company”) received a letter from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the Company’s minimum Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq listing rule 5550(b)(2). The notice has no immediate effect on the listing of the Company’s common stock, and the Company’s common stock continues to trade on the Nasdaq Capital Market under t
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069308/000095017023017313/0000950170-23-017313-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.